(1) In the pregnant women of study group, the gene frequency of
HLA-DR3 was significantly higher than that in control group (P < 0.05), but the frequency of
HLA-DR13 was significantly lower than those in control group (P < 0.05), while the frequencies of
HLA-DR4 and
HLA-DR15 had no significant difference between the two groups (P > 0.05). (2) The pregnant women with high replication condition of HBV had significantly higher frequency of
HLA-DR3 than those with low replication of HBV (P < 0.05). There was no significant difference of other phenotype between the two conditions. (3) The frequency of
HLA-DR3 of pregnant women in intrauterine
infection group was significantly higher than that of intrauterine non-
infection group (P < 0.05). There had no significant difference of the frequencies of
HLA-DR4,
HLA-DR13,
HLA-DR15 between the two groups (P > 0.05). The gene frequencies of
HLA-DR3,
HLA-DR4,
HLA-DR13,
HLA-DR15 were found no significant difference between the neonates of the study group and the control group (P > 0.05). Although the gene frequency of
HLA-DR3 (30.0%) in neonates of intrauterine
infection group was higher than that of intrauterine non-
infection group (7.4%), but no statistical difference was found between the two group (P > 0.05).
CONCLUSIONS:
HLA-DR3 is positively correlated with chronic HBV carrying and high replication conditions of pregnant women.
HLA-DR13 correlated negatively with chronic HBV carrying of the pregnant women.
HLA-DR3 carriers of pregnant women and their fetuses have a susceptibility of HBV
infection.